SLC2A1 and hepatocellular carcinoma: Meanwhile, SLC2A1-DT knockdown and overexpression shortened or prolonged the half-life of β-catenin protein, respectively, when HCC cells were treated with cycloheximide (CHX), a protein synthesis inhibitor (Fig. 4G, Fig. S3K and L).